Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,095 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma

NCT03697629

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
View Trial Details
Completed

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

NCT02178722

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • US Davis Cancer Center Sacramento, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
View all 24 locations
View Trial Details
Completed

Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma

NCT03111992

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Novartis Investigative Site Freiburg im Breisgau, Germany
  • Novartis Investigative Site Heidelberg, Germany
View Trial Details
Completed

Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT02077166

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Cedar Sinai Medical Center Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 40 locations
View Trial Details
Completed

Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment

NCT00210249

Conditions
Adnexal Diseases, Bladder Disease, Digestive System Diseases, +25 more
Locations
  • Centre de radiothérapie d'Agen Agen, France
  • Centre Hospitalier Universitaire d'Agen Agen, France
  • Clinique Esquirol Saint Hilaire Agen, France
  • Centre Hospitalier Universitaire de Bayonne Bayonne, France
View all 18 locations
View Trial Details

Related conditions